Compare Agilent Technologies Inc (A) vs Sibanye Stillwater Ltd (SBSW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Sibanye Stillwater Ltd — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Sibanye Stillwater Ltd trades at $10.61 (market cap $7.61B). The key difference: Agilent Technologies Inc is far larger — about 5.5× Sibanye Stillwater Ltd's market cap, and Sibanye Stillwater Ltd pays the higher dividend (2.91%). Which is the better fit depends on your goals.
| A | SBSW | |
|---|---|---|
Market Cap | $42.00B | $7.61B |
Sector | Health | Basic Materials |
52-Week High | $157.20 | $21.12 |
52-Week Low | $110.24 | $7.27 |
Enterprise Value | $43.55B | $9.26B |
Dividend Yield | 0.69% | 2.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Sibanye Stillwater (SBSW) surged 7.6% to $10.64, showing strong momentum despite negative profitability metrics. The stock trades at attractive valuation multiples with P/E of 4.76 and P/S of 0.95, while technical indicators signal bullish momentum. Recent earnings misses contrast with analyst optimism, with 42.9% recommending Buy and a $14.25 consensus target. The company faces challenges with negative net income margins but shows improving cash flow projections for 2025.
SBSW presents a value opportunity with deep undervaluation metrics, though profitability concerns and recent earnings misses warrant caution. The bullish technical setup and analyst support suggest potential upside, but investors must weigh the company's debt reduction progress against persistent negative margins. Key catalysts include PGM price recovery and management's debt reduction targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →
